SU1468413A3 - Способ получени 2-оксиндол-1-карбоксамидов или их фармацевтически приемлемых солей - Google Patents

Способ получени 2-оксиндол-1-карбоксамидов или их фармацевтически приемлемых солей Download PDF

Info

Publication number
SU1468413A3
SU1468413A3 SU864027453A SU4027453A SU1468413A3 SU 1468413 A3 SU1468413 A3 SU 1468413A3 SU 864027453 A SU864027453 A SU 864027453A SU 4027453 A SU4027453 A SU 4027453A SU 1468413 A3 SU1468413 A3 SU 1468413A3
Authority
SU
USSR - Soviet Union
Prior art keywords
phenyl
chlorophenyl
hydrogen
general formula
chlorine
Prior art date
Application number
SU864027453A
Other languages
English (en)
Russian (ru)
Inventor
Бернард Кадин Сол
Original Assignee
Пфайзер Инк. (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Инк. (Фирма) filed Critical Пфайзер Инк. (Фирма)
Application granted granted Critical
Publication of SU1468413A3 publication Critical patent/SU1468413A3/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/60Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SU864027453A 1984-05-04 1986-05-12 Способ получени 2-оксиндол-1-карбоксамидов или их фармацевтически приемлемых солей SU1468413A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60735684A 1984-05-04 1984-05-04

Publications (1)

Publication Number Publication Date
SU1468413A3 true SU1468413A3 (ru) 1989-03-23

Family

ID=24431933

Family Applications (1)

Application Number Title Priority Date Filing Date
SU864027453A SU1468413A3 (ru) 1984-05-04 1986-05-12 Способ получени 2-оксиндол-1-карбоксамидов или их фармацевтически приемлемых солей

Country Status (25)

Country Link
JP (1) JPS60243068A (enrdf_load_stackoverflow)
KR (1) KR870000497B1 (enrdf_load_stackoverflow)
AR (1) AR241159A1 (enrdf_load_stackoverflow)
BG (2) BG60208B2 (enrdf_load_stackoverflow)
CS (1) CS252828B2 (enrdf_load_stackoverflow)
DD (1) DD232916A5 (enrdf_load_stackoverflow)
EG (1) EG17193A (enrdf_load_stackoverflow)
ES (2) ES8609248A1 (enrdf_load_stackoverflow)
FI (1) FI80016C (enrdf_load_stackoverflow)
HU (1) HU196057B (enrdf_load_stackoverflow)
IE (1) IE851103L (enrdf_load_stackoverflow)
IN (1) IN161509B (enrdf_load_stackoverflow)
MA (1) MA20424A1 (enrdf_load_stackoverflow)
MW (1) MW1685A1 (enrdf_load_stackoverflow)
MX (1) MX5839A (enrdf_load_stackoverflow)
NO (1) NO163132C (enrdf_load_stackoverflow)
OA (1) OA08098A (enrdf_load_stackoverflow)
PL (2) PL147508B1 (enrdf_load_stackoverflow)
PT (1) PT80375B (enrdf_load_stackoverflow)
RO (2) RO91141B (enrdf_load_stackoverflow)
RU (1) RU2017729C1 (enrdf_load_stackoverflow)
SU (1) SU1468413A3 (enrdf_load_stackoverflow)
YU (1) YU44998B (enrdf_load_stackoverflow)
ZA (1) ZA853324B (enrdf_load_stackoverflow)
ZW (1) ZW7885A1 (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
IL95880A (en) * 1989-10-13 1995-12-31 Pfizer Use of 3-Transformed History of 2-Oxindole for the Preparation of Pharmaceuticals for Inhibition of Interlaukio-1 Biosynthesis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Rompps Chemic-Lexidon. Изд. 6-е, Т. III, 1966, 4849, *

Also Published As

Publication number Publication date
KR870000497B1 (ko) 1987-03-12
PT80375A (en) 1985-05-01
ES542813A0 (es) 1986-07-16
PL145416B1 (en) 1988-09-30
YU73085A (en) 1988-04-30
PL257892A1 (en) 1986-10-07
NO163132C (no) 1990-04-11
ES551275A0 (es) 1987-07-16
PL253203A1 (en) 1986-06-17
MW1685A1 (en) 1986-09-10
ES8707182A1 (es) 1987-07-16
IE851103L (en) 1985-11-04
ZW7885A1 (en) 1985-07-24
FI851756L (fi) 1985-11-05
JPS60243068A (ja) 1985-12-03
YU44998B (en) 1991-06-30
NO163132B (no) 1990-01-02
NO851774L (no) 1985-11-05
CS252828B2 (en) 1987-10-15
RO91141B (ro) 1987-07-03
KR850008154A (ko) 1985-12-13
RO94455B (ro) 1988-07-01
FI80016C (fi) 1990-04-10
ES8609248A1 (es) 1986-07-16
FI80016B (fi) 1989-12-29
OA08098A (fr) 1987-03-31
HUT37754A (en) 1986-02-28
RU2017729C1 (ru) 1994-08-15
BG60207B2 (en) 1993-12-30
DD232916A5 (de) 1986-02-12
EG17193A (en) 1990-08-30
ZA853324B (en) 1986-12-30
RO91141A (ro) 1987-06-30
PL147508B1 (en) 1989-06-30
JPH0335315B2 (enrdf_load_stackoverflow) 1991-05-27
RO94455A (ro) 1988-06-30
MA20424A1 (fr) 1985-12-31
AR241159A2 (es) 1991-12-30
PT80375B (pt) 1987-09-30
BG60208B2 (en) 1993-12-30
MX5839A (es) 1993-11-01
CS320285A2 (en) 1987-03-12
HU196057B (en) 1988-09-28
AR241159A1 (es) 1991-12-30
IN161509B (enrdf_load_stackoverflow) 1987-12-19
FI851756A0 (fi) 1985-05-03

Similar Documents

Publication Publication Date Title
ES2242890T3 (es) Agonistas beta 3 de oxindol 3-sustituido.
US4432979A (en) Pyridone compounds
US20090005363A1 (en) Organic Compounds
CN105566276B (zh) 作为dpp-4抑制剂的苯并六元环衍生物及其应用
CY1446A (en) Chemical compounds derived from cyclobutene
JP2002538142A (ja) 抗炎症、鎮痛性および抗血栓症活性を有するニトロキシ誘導体
JPH0826018B2 (ja) アザオキシインドール誘導体
JPH05178840A (ja) ピリミジンの新誘導体、それらの製造法、得られる中間体、それらの薬剤としての使用及びそれらを含有する製薬組成物
JPH0313235B2 (enrdf_load_stackoverflow)
JPS6345259A (ja) ピリジン−3−カルボキサミド誘導体
JPH07330764A (ja) 新規なn−ピリジルカルボキサミドと誘導体、その製造方法及びそれらを含む薬剤組成物
ES2782357T3 (es) Inhibidores de IRE 1 alfa
RU2114833C1 (ru) Арил-конденсированные 2,4-диазепиновые соединения, промежуточные продукты, антиаритмический агент и композиция
WO2019031471A1 (ja) 脂肪性肝疾患の治療剤及び肥満症の治療剤
SU1468413A3 (ru) Способ получени 2-оксиндол-1-карбоксамидов или их фармацевтически приемлемых солей
CN103145706A (zh) 一类具有抗炎作用的咪唑并吡啶类化合物及其在制备抗炎药物中的应用
JP2709530B2 (ja) 抗炎症薬としてのオキシンドール1−[n−(アルコキシカルボニル)]カルボキサミド類および1−(n−カルボキサミド)カルボキサミド類
JPS61109767A (ja) オキシンドール抗炎症剤
JPS63243074A (ja) ピリジンの新誘導体、それらの製造法及び中間体、薬剤としての使用並びにそれらを含む組成物
DE2920861A1 (de) Phenylaminothiophenessigsaeuren, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
JPH02202865A (ja) 新規α―シアノ―β―オキソプロピオンアミド
TW202413335A (zh) Nav1.8抑制劑
US4025508A (en) 6-(Trifluoromethyl)-benzothiadiazines
NO810126L (no) Fremgangsmaate for fremstilling av nye pyridazinderivater
US4431657A (en) Analgesic compositions consisting of 2H-benzothieno[3,2-c]pyrazol-3-amine derivatives